Human umbilical cord and placental blood plasma Uses, Dosage, Side Effects and more
Human umbilical cord and placental blood plasma is platelet-poor plasma that is derived by fractionation from sterile umbilical cord and placental blood. It is developed by Cellpraxis and is currently being investigated against severe acute respiratory syndrome (SARS).
| Trade Name | Human umbilical cord and placental blood plasma |
| Generic | PlasmaCord |
| PlasmaCord Other Names | Human umbilical cord and placental blood plasma |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
